Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
 1 a 20 de 85 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
2. Cita con resumen
Campins M, Moraga-Llop FA. Novetats en el calendari vacunal de Catalunya 2016. Butlletí d'Informació Terapèutica 2016;27:60-5. [Ref.ID 101346]
3. Cita con resumen
Kmietowicz Z. Pfizer and Allergan agree $160bn merger deal. BMJ 2015;351:h6342. [Ref.ID 99704]
4. Cita con resumen
Day M. Italian expert questions need for expanded vaccination schedule. BMJ 2015;351:h6181. [Ref.ID 99693]
5. Cita con resumen
Anónimo. Generics cut into Pfizer profits, but oncology drug sales remain strong. DIA Daily 2013:30 de octubre. [Ref.ID 96273]
6. Cita con resumen
Griffin MR, Zhu Y, Moore MR, Withney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013;369:155-63. [Ref.ID 95819]
7. Cita con resumen
Anónimo. EC regulator approves pneumococcal vaccine for wider use. DIA Daily 2013:11 de julio. [Ref.ID 95643]
8.Tiene citas relacionadas
Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, Puumalainen T, Lommel P, Hezareh M, Moreira M, Schuerman L, Kilpi TM. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet 2013;381:214-22. [Ref.ID 94797]
9.Tiene citas relacionadas
Whitney CG. More evidence for use of pneumococcal conjugate vaccines. Lancet 2013;381:182-3. [Ref.ID 94794]
10. Cita con resumen
Anónimo. Pneumococcal vaccine for adults. Med Lett Drugs Ther 2012;54:87-8. [Ref.ID 93956]
11. Cita con resumen
Garbe E, Andersohn F, Bronder E, Salama A, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Meyer O, Kurtal H. Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 2012;68:821-32. [Ref.ID 92827]
12.Tiene citas relacionadas
Anónimo. Un vaccin conjugué à 10 valences dans certains pays. Prescrire 2010;30:656. [Ref.ID 89285]
13.Tiene citas relacionadas
Anónimo. Vaccine pneumococcique conjugué à 13 valences. Séduisant mais à surveiller. Prescrire 2010;30:653-7. [Ref.ID 89284]
14.Tiene citas relacionadas
Tseng HF, Jacobsen SJ. Pneumococcal vaccination and cardiovascular events in men. In reply. JAMA 2010;304:743. [Ref.ID 89147]
15.Tiene citas relacionadas
Kaczorowski J. Pneumococcal vaccination and cardiovascular events in men. JAMA 2010;304:742-3. [Ref.ID 89146]
16.
Anónimo. A new conjugate meningococcal vaccine (Menveo). Med Lett Drugs Ther 2010;52:59-60. [Ref.ID 89044]
17.Enlace a cita original
Rozenbaum MH, Sanders EAM, vanHoek A, Jansen AGSC, van der Ende A, van den Dobbelsteen G, Rodenburg GD, Hak E, Postma MJ. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines. BMJ 2010;340:1347. [Ref.ID 88710]
18.Tiene citas relacionadas
Madjid M, Musher DM. Preventing myocardial infarction with vaccination. Myths and realities. JAMA 2010;303:1751-2. [Ref.ID 88404]
19.Tiene citas relacionadas Cita con resumen
Tseng HF, Slezak JM, Quinn VP, Sy LS, Van Den Eeden SK, Jacobsen SJ. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010;303:1699-706. [Ref.ID 88401]
20.Tiene citas relacionadas Cita con resumen
Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, D'Alessandro-Gabazza C, Nakayama S, Nishikubo K, Noguchi T, Takei Y, Gabazza EC. Efficacy of 23-valent pnemococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ 2010;340:579. [Ref.ID 88118]
Seleccionar todas
 
 1 a 20 de 85 siguiente >>